Adial Pharmaceuticals Inc...

NASDAQ: ADILW · Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jul 27, 2023, 9:52 PM

Adial Pharmaceuticals WT EXP 073123 Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-13.2M -7M -12.73M -19.42M
Depreciation & Amortization
565.00 564.00 60.5K 55.11K
Stock-Based Compensation
796.83K 1.82M 3.37M 4.24M
Other Working Capital
215.13K -634.79K -1.48M 1.82M
Other Non-Cash Items
5.09M 1.07M -522K 1.81M
Deferred Income Tax
n/a -1.91M -502 -94.08K
Change in Working Capital
386.14K -794.21K -1.37M 1.46M
Operating Cash Flow
-6.92M -6.81M -11.19M -11.95M
Capital Expenditures
n/a 6.81M n/a -64.61K
Cash Acquisitions
n/a n/a n/a 30.59K
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 1.5M n/a -0.00
Investing Cash Flow
n/a 1.5M n/a -34.02K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -1.66K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.82M n/a 1.86K 1.89M
Financial Cash Flow
7.85M 4.13M 9.13M 13.64M
Net Cash Flow
923.44K -1.17M -2.06M 1.66M
Free Cash Flow
-6.92M n/a -11.19M -12.01M